Scientists from the Wellcome Sanger Institute (UK), as part of a research team, have developed a new screening tool called scSNV-seq, which can identify genetic changes associated with Alzheimer’s disease, cardiovascular diseases and cancer. Research results published In the scientific journal Genome Biology.
A new method for diagnosing diseases is based on analysis of human genetic samples. It allows you to quickly evaluate the impact of thousands of genetic changes in cells that have never been screened before. At the same time, the use of scSNV-seq provides not only information about risks in a detected mutation, but also comprehensive analysis.
It has been noted that ScSNV-seq can accurately classify different types of genetic changes into three categories: benign, dysfunctional, and function-altering. In addition, innovative technology makes it easier to study changes in the structure and function of complex cells in the human body, such as immune T cells and neurons.
The study authors emphasized that the new method accelerates the identification of genetic mutations that cause autoimmune, cardiovascular and neurodegenerative diseases. They hope that the use of ScSNV-seq will further contribute to the development of new advanced treatments for them.
used to be a doctor explainedThose who need genetic testing for cancer risk.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.